Lipid metabolism modulators

“Lipid metabolism modulators” is a general designation for a class of molecules (including proteins, receptors, enzymes, and transporters) that are involved in the regulation of lipid biosynthesis, storage, breakdown, and cellular transport. These targets are therapeutically modulated in a range of diseases—from cardiovascular and metabolic disorders to neurodegeneration and cancer—by drugs that inhibit enzyme activity (such as statins or lipase inhibitors), activate nuclear receptors affecting lipid gene transcription (such as PPAR or LXR agonists), or shift fatty acid transport and signaling. As a category, “lipid metabolism modulator” is not a single druggable entity but encompasses an array of molecular targets that individually meet the criteria for “therapeutic target” status[1][3]. If you seek information for a particular target in this category (e.g., “Liver X receptor,” “HMG-CoA reductase,” or “Sphingosine-1-phosphate receptor”), please specify; structured information can then be provided for that individual molecule/receptor.

Other names

Lipid regulatorslipid metabolism targetslipid pathway modulators

Inhibition of cholesterol synthesis (statins); Modulation of fatty acid oxidation (PPAR agonists); Promotion of cholesterol efflux (LXR agonists, ABCA1 activators); Regulation of gene transcription involved in lipid handling.